Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Bialer

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Epilepsia|October 4, 2012
Comments on the working group's 2012 review of the ProgramMeir Bialer
Biopharmaceutics & Drug Disposition|April 27, 2004
The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body modelEyal Sobol, Meir Bialer
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
Valproic Acid: second generationMeir Bialer, Boris Yagen
Drugs|March 1, 2026
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three DecadesMeir Bialer, Emilio Perucca
Epilepsia|January 21, 2020
Pharmacokinetic and pharmacodynamic analysis of (2S,3S)-sec-butylpropylacetamide (SPD) in rats and pigs-A CNS-active stereoisomer of SPDDavid Bibi, Meir Bialer
Epilepsia|July 6, 2020
Response: Cannabidiol antiseizure activity and its interactions with clobazam: "It's déjà vu all over again" Yogi BerraMeir Bialer, Emilio Perucca
Epilepsia|May 27, 2020
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trialsMeir Bialer, Emilio Perucca
Biopharmaceutics & Drug Disposition|December 23, 2004
Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profilesEyal Sobol, Meir Bialer
Biopharmaceutics & Drug Disposition|February 12, 2004
Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approachEyal Sobol, Meir Bialer
CNS Drugs|January 30, 2022
Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine?Meir Bialer, Emilio Perucca
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Epilepsia|October 4, 2012
Comments on the working group's 2012 review of the ProgramMeir Bialer
Biopharmaceutics & Drug Disposition|April 27, 2004
The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body modelEyal Sobol, Meir Bialer
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|January 3, 2007
Valproic Acid: second generationMeir Bialer, Boris Yagen
Drugs|March 1, 2026
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three DecadesMeir Bialer, Emilio Perucca
Epilepsia|January 21, 2020
Pharmacokinetic and pharmacodynamic analysis of (2S,3S)-sec-butylpropylacetamide (SPD) in rats and pigs-A CNS-active stereoisomer of SPDDavid Bibi, Meir Bialer
Epilepsia|July 6, 2020
Response: Cannabidiol antiseizure activity and its interactions with clobazam: "It's déjà vu all over again" Yogi BerraMeir Bialer, Emilio Perucca
Epilepsia|May 27, 2020
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trialsMeir Bialer, Emilio Perucca
Biopharmaceutics & Drug Disposition|December 23, 2004
Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profilesEyal Sobol, Meir Bialer
Biopharmaceutics & Drug Disposition|February 12, 2004
Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approachEyal Sobol, Meir Bialer
CNS Drugs|January 30, 2022
Lorcaserin for Dravet Syndrome: A Potential Advance Over Fenfluramine?Meir Bialer, Emilio Perucca
Pageof 16